Searched over 200M research papers
10 papers analyzed
These studies suggest insulin therapy can cause hypoglycemia, weight gain, injection site abnormalities, insulin allergy, and psychological issues, while some studies suggest it can also increase cardiovascular risk and mortality in type 2 diabetes patients.
20 papers analyzed
Hypoglycemia, or low blood glucose, is the most frequently reported side effect of insulin therapy. It is potentially serious and can be life-threatening if not managed properly . Tight glucose control, which is often the goal of insulin therapy, increases the risk of severe hypoglycemia three-fold in both type 1 and type 2 diabetes patients. This necessitates individualized therapy and glycemia goals to minimize this risk.
Weight gain is another common side effect of insulin therapy . Additionally, insulin administration can lead to various injection site complications such as lipoatrophy (loss of fat tissue) and lipohypertrophy (accumulation of fat tissue), which can cause fluctuations in blood glucose levels . These complications are particularly prevalent in young patients with type 1 diabetes, with lipohypertrophy affecting nearly 12% of patients.
Although rare, insulin allergy can occur and manifest as local or systemic allergic reactions . Dermatological complications, including rashes and skin inflammation at the injection site, are also reported . These reactions can sometimes be severe enough to necessitate a change in the type of insulin used.
Insulin therapy has been associated with an increased risk of cardiovascular (CV) events and mortality, particularly in type 2 diabetes patients. This increased risk is dose-dependent and linked to factors such as weight gain, recurrent hypoglycemia, and iatrogenic hyperinsulinemia, which can lead to inflammation, atherosclerosis, and other cardiovascular issues.
Insulin therapy can also have psychological and behavioral side effects. Needle-phobia, psychological stress, and an increased risk of suicide have been reported as adverse events related to insulin and its administration. These factors can significantly impact a patient's quality of life and adherence to treatment.
Long-term use of continuous subcutaneous insulin infusion (CSII) has shown benefits in metabolic control but also comes with its own set of side effects, such as skin inflammation and a risk of diabetic ketoacidosis. However, the rates of severe hypoglycemia and ketoacidosis are generally lower compared to other insulin delivery methods.
Insulin therapy, while essential for managing diabetes, comes with a range of side effects that can impact both short-term and long-term health. Hypoglycemia remains the most common and serious side effect, but weight gain, injection site complications, cardiovascular risks, and psychological issues also pose significant challenges. Continuous monitoring and individualized treatment plans are crucial to mitigate these risks and improve patient outcomes.
Most relevant research papers on this topic